To further assess the role of tau in mediating the facilitation of LTD by extracts of Alzheimer’s disease brain, which inhibit LTP in a tau-dependent manner, we tested another, similar, extract (‘AD1’)34 (Table 1). This evidence concerns the gene MAPT and Alzheimer disease.